Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

XCage™ Interbody Fusion System

K-Number: K160076 · 2016-10-13

Decision Date2016-10-13
Product CodeMAX
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

XCage™ Interbody Fusion System is a medical device manufactured by Ouroboros Medical, Inc.. It received FDA 510(k) clearance on 2016-10-13 under approval number K160076. The device is classified under product code MAX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the XCage™ Interbody Fusion System?

XCage™ Interbody Fusion System is a medical device that received FDA 510(k) clearance on 2016-10-13. It is manufactured by Ouroboros Medical, Inc.. The 510(k) number is K160076.

When was XCage™ Interbody Fusion System approved by the FDA?

XCage™ Interbody Fusion System received FDA 510(k) clearance on 2016-10-13, under approval number K160076.

What company makes XCage™ Interbody Fusion System?

XCage™ Interbody Fusion System is manufactured by Ouroboros Medical, Inc..

What is the FDA product code for XCage™ Interbody Fusion System?

The FDA product code for XCage™ Interbody Fusion System is MAX.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: MAX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.